PF-Atlas › Clinical Trials › NCT02718495

Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis

PTI-428 · Phase 1

Registry ID

NCT02718495

Phase

Phase 1

Status

Completed

Drug / intervention

PTI-428

Sponsor

Proteostasis Therapeutics, Inc.

Start

2016-07-19

About this trial

PTI-428 is evaluated in NCT02718495, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Proteostasis Therapeutics, Inc.. Current status: Completed.

View NCT02718495 on ClinicalTrials.gov →

Explore related

All PTI-428 trials All IPF trials

Related trials

PTI-428 — NCT03258424

Medical disclaimer. This page summarizes public trial data for NCT02718495 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.